Sutro Biopharma STRO Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Sutro Biopharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's change in lease liabilities?
- Sutro Biopharma (STRO) reported change in lease liabilities of -$2.04M in Q1 2026.
- How has Sutro Biopharma's change in lease liabilities changed year-over-year?
- Sutro Biopharma's change in lease liabilities decreased by 16.2% year-over-year, from -$1.76M to -$2.04M.
- What is the long-term trend for Sutro Biopharma's change in lease liabilities?
- Over 4 years (2021 to 2025), Sutro Biopharma's change in lease liabilities has grown at a 28.7% compound annual growth rate (CAGR), from -$2.73M to -$7.48M.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.